Dow Up 0.35% Nasdaq Down 0.02%

Gilead Sciences Inc. (GILD)

-NasdaqGS
100.79 0.49(0.48%) Aug 20, 4:00PM EDT
|Pre-Market : 101.00 Up 0.21 (0.21%) 8:52AM EDT - Nasdaq Real Time Price
Prev Close:101.28
Open:100.71
Bid:101.20 x 400
Ask:101.29 x 100
1y Target Est:111.43
Beta:1.01
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:100.61 - 102.57
52wk Range:58.50 - 102.57
Volume:12,603,809
Avg Vol (3m):11,573,400
Market Cap:152.36B
P/E (ttm):37.33
EPS (ttm):2.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 0.48%152.36B
GSK114.84B
PFE183.19B
RHHBY247.66B

Key Statistics

Forward P/E (1 yr):10.78
P/S (ttm):8.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :8.00
Quarterly EPS Est (Sep-14) :1.89
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.51

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback